Analysts at JMP Securities initiated coverage on shares of Vanda Pharmaceuticals (NASDAQ: VNDA ) with an “outperform” rating. Vanda Pharmaceuticals' shares closed at $4.00 yesterday. Vanda Pharmaceuticals' trailing-twelve-month revenue is $33.18 million. RBC Capital initiated coverage on shares of U.S. Silica Holdings (NYSE: SLCA ) with a “sector perform”